Anticancer Effects of Dihydroartemisinin on Human Esophageal Cancer Cells In Vivo

Despite recent advances in chemotherapy and surgical resection, the 5-year survival rate of esophageal cancer still remains at the low level. Therefore, it is very important to discover a new agent to improve the life expectancy of patients with esophageal cancer. Dihydroartemisinin (DHA), a semisyn...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Cailing, Li, Shumin, Li, Yanjing, Bai, Yuxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985077/
https://www.ncbi.nlm.nih.gov/pubmed/29888170
http://dx.doi.org/10.1155/2018/8759745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985077/
https://www.ncbi.nlm.nih.gov/pubmed/29888170
http://dx.doi.org/10.1155/2018/8759745

Ejemplares similares